Juhaeri Juhaeri
Juhaeri Juhaeri
In the last two decades there has been a shift in the approach to evaluating the benefit-risk (BR) profiles of medicinal products from an unstructured, subjective, and inconsistent, to a more structured and objective, process. This article ...
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis [0.03%]
舒更葡糖钠注射液致支气管痉挛和冠状动脉痉挛的风险：基于药品不良反应的分析
Pushkar Aggarwal
Pushkar Aggarwal
Introduction: Sugammadex is used for the reversal of neuromuscular blockade caused by rocuronium bromide and vecuronium bromide. As part of the post licensing phase of drug development, adverse events related to the use o...
Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance [0.03%]
基于假设的信号检测在医疗数据库中的应用：对药物警戒的价值评估
Andrew Bate,Ken Hornbuckle,Juhaeri Juhaeri et al.
Andrew Bate et al.
Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada [0.03%]
药品上市后监管：英国和加拿大有效运行的关键方面和措施综述
Nikhil Raj,Swapnil Fernandes,Narayana R Charyulu et al.
Nikhil Raj et al.
Regulatory approvals for the marketing of medicinal products authorize medical practitioners to prescribe drugs to a group of patients that are defined within the license of the medicinal product. However, such prescriptions are carried out...
Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada [0.03%]
市场监督：英国和加拿大背景下有效运行的关键方面和措施综述
Nikhil Raj,Swapnil Fernandes,Narayana R Charyulu et al.
Nikhil Raj et al.
Regulatory approvals for the marketing of medicinal products authorize medical practitioners to prescribe drugs to a group of patients that are defined within the license of the medicinal product. However, such prescriptions are carried out...
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo [0.03%]
资源匮乏国家药品不良反应监察系统的建立——刚果民主共和国的经验总结
Didier Nzolo,Andrea Kuemmerle,Yves Lula et al.
Didier Nzolo et al.
Implementation of pharmacovigilance (PV) systems in resource-limited countries is a real endeavor. Despite country- and continent-specific challenges, the Democratic Republic of the Congo (DRC) has been able to develop one of the most activ...
Pharmacist-assisted electronic prescribing at the time of admission to an inpatient orthopaedic unit and its impact on medication errors: a pre- and postintervention study [0.03%]
住院骨科病房入院时在药剂师协助下进行电子处方及其对药物错误的影响：一项干预前后研究
Tim Tran,Simone E Taylor,Andrew Hardidge et al.
Tim Tran et al.
Background: Prescribing and administration errors related to pre-admission medications are common amongst orthopaedic inpatients. Postprescribing medication reconciliation by clinical pharmacists after hospital admission ...
Drug change: 'a hassle like no other'. An in-depth investigation using the Danish patient safety database and focus group interviews with Danish hospital personnel [0.03%]
药物更换：“无与伦比的麻烦”。基于丹麦患者安全数据库的深入调查和与丹麦医院人员的重点小组访谈
Joo Hanne Poulsen,Rikke Mie Rishøj,Hanne Fischer et al.
Joo Hanne Poulsen et al.
Background: Drug change (DC) is a common challenge in Danish hospitals. It affects the work of hospital personnel and has potentially serious patient safety consequences. Focus on medication safety is becoming increasingl...
Ceftolozane-tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series [0.03%]
用于治疗多重耐药病原体所致骨髓炎的头孢他啶-阿维巴坦：一系列病例报告
Xing Tan,Ryan P Moenster
Xing Tan
Ceftolozane-tazobactam (CT) is a recently approved novel cephalosporin and β-lactamase inhibitor combination agent with in vitro activity against various Gram-positive and Gram-negative pathogens, including several multidrug-resistant (MDR...
Amy H Chung,Lois La Grenade,Lisa M Harinstein
Amy H Chung
Background: Intense pruritus or itching emerging after discontinuation of cetirizine has been the subject of postmarketing reports submitted to the U.S. Food and Drug Administration (FDA), published in the medical literat...